NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹54 Cr | ₹35 Cr | ₹68 Cr | ₹80 Cr | ₹1,975,921 Cr |
What is the latest Operating Profit of NGL FINECHEM ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹54 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹1,975,921 Cr |
How is Operating Profit of NGL FINECHEM Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹54 Cr | 53.73 | |
| Mar2024 | ₹35 Cr | -48.74 | |
| Mar2023 | ₹68 Cr | -14.87 | |
| Mar2022 | ₹80 Cr | -100.00 | |
| Mar2021 | ₹1,975,921 Cr | - | |
Compare Operating Profit of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,381.4 Cr | 5% | -7.4% | 85.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 5% |
-7.4% |
85.7% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses